세계의 보툴리눔톡신(보톡스) 시장 : 시장 점유율과 순위, 전체 판매 및 수요 예측(2025-2031년)

The global market for Botulinum Toxins was estimated to be worth US$ 9479 million in 2024 and is forecast to a readjusted size of US$ 15800 million by 2031 with a CAGR of 7.7% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Botulinum Toxins cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Botulinum Toxin is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin also used commercially in medicine, cosmetics.

The global botulinum toxin market is driven primarily by the increasing demand for aesthetic procedures and the growing acceptance of minimally invasive treatments. Rising consumer awareness of anti-aging solutions, coupled with the influence of social media and celebrity endorsements, has significantly boosted the use of botulinum toxin in cosmetic applications. In addition, expanding therapeutic indications-such as for chronic migraine, spasticity, and overactive bladder-are further fueling market growth, supported by ongoing clinical research and regulatory approvals.

Despite strong demand, the botulinum toxin market faces challenges such as high treatment costs, especially in emerging economies, which can limit patient accessibility. Moreover, strict regulatory frameworks, risks of off-label use, and potential side effects-such as resistance due to neutralizing antibodies-pose constraints on market expansion. Competition from alternative aesthetic and therapeutic modalities, along with the entry of biosimilar products, also adds pricing and innovation pressure on established brands.

North America is the largest consumption place, with a revenue market share nearly 60% in 2024. Following North America, Europe is the second largest consumption place with the revenue market share of 16%. the global key manufacturers of Botulinum Toxin include AbbVie, Galderma, Ipsen, Daewoong, LIBP, etc. In 2024, the global top five players had a share approximately 94.0% in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Botulinum Toxins, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Botulinum Toxins by region & country, by Type, and by Application.

The Botulinum Toxins market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Botulinum Toxins.

Market Segmentation

By Company

• AbbVie
• Ipsen
• Medytox
• LIBP
• Merz Pharmaceuticals
• Hugel
• Daewoong
• US World Meds
• Revance
• Galderma

Segment by Type

• 50IU/Vial
• 100IU/Vial
• Other

Segment by Application

• Medical
• Cosmetic

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Botulinum Toxins manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Botulinum Toxins in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Botulinum Toxins in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Botulinum Toxins Product Introduction
• 1.2 Global Botulinum Toxins Market Size Forecast
  • 1.2.1 Global Botulinum Toxins Sales Value (2020-2031)
  • 1.2.2 Global Botulinum Toxins Sales Volume (2020-2031)
  • 1.2.3 Global Botulinum Toxins Sales Price (2020-2031)
• 1.3 Botulinum Toxins Market Trends & Drivers
  • 1.3.1 Botulinum Toxins Industry Trends
  • 1.3.2 Botulinum Toxins Market Drivers & Opportunity
  • 1.3.3 Botulinum Toxins Market Challenges
  • 1.3.4 Botulinum Toxins Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Botulinum Toxins Players Revenue Ranking (2024)
• 2.2 Global Botulinum Toxins Revenue by Company (2020-2025)
• 2.3 Global Botulinum Toxins Players Sales Volume Ranking (2024)
• 2.4 Global Botulinum Toxins Sales Volume by Company Players (2020-2025)
• 2.5 Global Botulinum Toxins Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Botulinum Toxins Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Botulinum Toxins Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Botulinum Toxins
• 2.9 Botulinum Toxins Market Competitive Analysis
  • 2.9.1 Botulinum Toxins Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Botulinum Toxins Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Botulinum Toxins as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 50IU/Vial
  • 3.1.2 100IU/Vial
  • 3.1.3 Other
• 3.2 Global Botulinum Toxins Sales Value by Type
  • 3.2.1 Global Botulinum Toxins Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Botulinum Toxins Sales Value, by Type (2020-2031)
  • 3.2.3 Global Botulinum Toxins Sales Value, by Type (%) (2020-2031)
• 3.3 Global Botulinum Toxins Sales Volume by Type
  • 3.3.1 Global Botulinum Toxins Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Botulinum Toxins Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Botulinum Toxins Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Botulinum Toxins Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Medical
  • 4.1.2 Cosmetic
• 4.2 Global Botulinum Toxins Sales Value by Application
  • 4.2.1 Global Botulinum Toxins Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Botulinum Toxins Sales Value, by Application (2020-2031)
  • 4.2.3 Global Botulinum Toxins Sales Value, by Application (%) (2020-2031)
• 4.3 Global Botulinum Toxins Sales Volume by Application
  • 4.3.1 Global Botulinum Toxins Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Botulinum Toxins Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Botulinum Toxins Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Botulinum Toxins Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Botulinum Toxins Sales Value by Region
  • 5.1.1 Global Botulinum Toxins Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Botulinum Toxins Sales Value by Region (2020-2025)
  • 5.1.3 Global Botulinum Toxins Sales Value by Region (2026-2031)
  • 5.1.4 Global Botulinum Toxins Sales Value by Region (%), (2020-2031)
• 5.2 Global Botulinum Toxins Sales Volume by Region
  • 5.2.1 Global Botulinum Toxins Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Botulinum Toxins Sales Volume by Region (2020-2025)
  • 5.2.3 Global Botulinum Toxins Sales Volume by Region (2026-2031)
  • 5.2.4 Global Botulinum Toxins Sales Volume by Region (%), (2020-2031)
• 5.3 Global Botulinum Toxins Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Botulinum Toxins Sales Value, 2020-2031
  • 5.4.2 North America Botulinum Toxins Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Botulinum Toxins Sales Value, 2020-2031
  • 5.5.2 Europe Botulinum Toxins Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Botulinum Toxins Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Botulinum Toxins Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Botulinum Toxins Sales Value, 2020-2031
  • 5.7.2 South America Botulinum Toxins Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Botulinum Toxins Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Botulinum Toxins Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Botulinum Toxins Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Botulinum Toxins Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Botulinum Toxins Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Botulinum Toxins Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Botulinum Toxins Sales Value, 2020-2031
  • 6.3.2 United States Botulinum Toxins Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Botulinum Toxins Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Botulinum Toxins Sales Value, 2020-2031
  • 6.4.2 Europe Botulinum Toxins Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Botulinum Toxins Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Botulinum Toxins Sales Value, 2020-2031
  • 6.5.2 China Botulinum Toxins Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Botulinum Toxins Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Botulinum Toxins Sales Value, 2020-2031
  • 6.6.2 Japan Botulinum Toxins Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Botulinum Toxins Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Botulinum Toxins Sales Value, 2020-2031
  • 6.7.2 South Korea Botulinum Toxins Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Botulinum Toxins Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Botulinum Toxins Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Botulinum Toxins Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Botulinum Toxins Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Botulinum Toxins Sales Value, 2020-2031
  • 6.9.2 India Botulinum Toxins Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Botulinum Toxins Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 AbbVie
  • 7.1.1 AbbVie Company Information
  • 7.1.2 AbbVie Introduction and Business Overview
  • 7.1.3 AbbVie Botulinum Toxins Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 AbbVie Botulinum Toxins Product Offerings
  • 7.1.5 AbbVie Recent Development
• 7.2 Ipsen
  • 7.2.1 Ipsen Company Information
  • 7.2.2 Ipsen Introduction and Business Overview
  • 7.2.3 Ipsen Botulinum Toxins Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Ipsen Botulinum Toxins Product Offerings
  • 7.2.5 Ipsen Recent Development
• 7.3 Medytox
  • 7.3.1 Medytox Company Information
  • 7.3.2 Medytox Introduction and Business Overview
  • 7.3.3 Medytox Botulinum Toxins Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Medytox Botulinum Toxins Product Offerings
  • 7.3.5 Medytox Recent Development
• 7.4 LIBP
  • 7.4.1 LIBP Company Information
  • 7.4.2 LIBP Introduction and Business Overview
  • 7.4.3 LIBP Botulinum Toxins Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 LIBP Botulinum Toxins Product Offerings
  • 7.4.5 LIBP Recent Development
• 7.5 Merz Pharmaceuticals
  • 7.5.1 Merz Pharmaceuticals Company Information
  • 7.5.2 Merz Pharmaceuticals Introduction and Business Overview
  • 7.5.3 Merz Pharmaceuticals Botulinum Toxins Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Merz Pharmaceuticals Botulinum Toxins Product Offerings
  • 7.5.5 Merz Pharmaceuticals Recent Development
• 7.6 Hugel
  • 7.6.1 Hugel Company Information
  • 7.6.2 Hugel Introduction and Business Overview
  • 7.6.3 Hugel Botulinum Toxins Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Hugel Botulinum Toxins Product Offerings
  • 7.6.5 Hugel Recent Development
• 7.7 Daewoong
  • 7.7.1 Daewoong Company Information
  • 7.7.2 Daewoong Introduction and Business Overview
  • 7.7.3 Daewoong Botulinum Toxins Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Daewoong Botulinum Toxins Product Offerings
  • 7.7.5 Daewoong Recent Development
• 7.8 US World Meds
  • 7.8.1 US World Meds Company Information
  • 7.8.2 US World Meds Introduction and Business Overview
  • 7.8.3 US World Meds Botulinum Toxins Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 US World Meds Botulinum Toxins Product Offerings
  • 7.8.5 US World Meds Recent Development
• 7.9 Revance
  • 7.9.1 Revance Company Information
  • 7.9.2 Revance Introduction and Business Overview
  • 7.9.3 Revance Botulinum Toxins Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 Revance Botulinum Toxins Product Offerings
  • 7.9.5 Revance Recent Development
• 7.10 Galderma
  • 7.10.1 Galderma Company Information
  • 7.10.2 Galderma Introduction and Business Overview
  • 7.10.3 Galderma Botulinum Toxins Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 Galderma Botulinum Toxins Product Offerings
  • 7.10.5 Galderma Recent Development

8 Industry Chain Analysis

• 8.1 Botulinum Toxins Industrial Chain
• 8.2 Botulinum Toxins Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Botulinum Toxins Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Botulinum Toxins Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer